Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
26.87
+0.53 (2.01%)
At close: Jun 26, 2026, 4:00 PM EDT
26.87
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:35 PM EDT
Bicara Therapeutics Employees
Bicara Therapeutics had 103 employees as of December 31, 2025. The number of employees increased by 48 or 87.27% compared to the previous year.
Employees
103
Change (1Y)
48
Growth (1Y)
87.27%
Revenue / Employee
n/a
Profits / Employee
-$1,527,330
Market Cap
1.77B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 103 | 48 | 87.27% |
| Dec 31, 2024 | 55 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Vir Biotechnology | 367 |
| UroGen Pharma | 298 |
| Capricor Therapeutics | 231 |
| Monte Rosa Therapeutics | 187 |
| Innoviva | 159 |
| Septerna | 130 |
| AnaptysBio | 104 |
BCAX News
- 5 weeks ago - Bicara Therapeutics Transcript: Study update - Transcripts
- 5 weeks ago - Bicara Therapeutics Press release: Study update - Filings
- 5 weeks ago - Bicara Therapeutics Slides: Study update - Filings
- 5 weeks ago - Bicara Therapeutics management to meet with Cantor - TheFly
- 5 weeks ago - Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC - GlobeNewsWire
- 6 weeks ago - Bicara Therapeutics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Bicara Therapeutics price target raised to $37 from $36 at Morgan Stanley - TheFly